-
In an interview to CNBC-TV18, Kaushal Soparkar, MD of Meghmani Organics spoke about the results and his outlook for the company.
-
Meghmani Organics is buzzing in trade; it's up 150 percent in the last six months. In an interview to CNBC-TV18, Kaushal Soparkar, MD of the company spoke about the latest happenings and his outlook going ahead.
-
In an interview to CNBC-TV18, Ashish Soparkar, MD of Meghmani Organics spoke about the latest happenings in the company and his outlook going ahead.
-
Sunidhi Securities initiated coverage with a buy rating on Meghmani Organics. In an interview to CNBC-TV18, Ashish Soparkar, MD of Meghmani Organics spoke about the latest happenings in his company and sector.
-
Meghmani Organics posted a strong revenue growth in Q1 and margins were aided by agro-chemical business. In an interview to CNBC-TV18, Ashish Soparkar, MD of Meghmani Organics spoke about the results and his outlook for the company.
-
In an interview to CNBC-TV18, Ashish Soparkar, MD of Meghmani Organics said that chloromethane plant will be commissioned in Q4 of FY18.
-
Meghmani Organics, a chemical company that is into pigment products and a range of pesticides reported a steady set of numbers this quarter. There is an improvement in margins and profits as well aided by lower finance costs.
-
Soparkar expects the company's topline to grow by Rs 300-350 crore in FY17 and an additional Rs 350 crore in FY18.
-
In an interview to CNBC-TV18, the company‘s Managing Director Ashish Soparkar said that the company will have 15-20 percent of market size for the technical product.
-
The expected earnings before interest, tax, depreciation and amortisation (EBITDA) for the new plant at Bharuch is expected at around 30 percent, says Natwarlal M Patel, managing director of Meghmani Organics.
-
In an interview with CNBC-TV18, Natu Patel, MD of Meghmani Organics, discussed the recent slowdown in the Chinese speciality chemicals market and what it means for Indian companies such as his.
-
The basic chemical business is seeing very good growth because it is directly related to India‘s growth, said Ashish Soparkar, MD, Meghmani Organics, adding that the capacity utilisation for the segment is also at its optimum currently.
-
The company currently is sitting on a land bank of 2.7 million square feet at Sanand but has not plans of monetising it, said Ashish Soparkar, MD, Meghmani Organics.
-
Meghmani Organics has announced a joint venture with two Japan-based companies to produce resins for chlorinated polyvinyl chloride (CPVC), which is currently imported from US and Japan.
-
Speaking to CNBC-TV18, Ashish Soparkar, managing director of Meghmani Organics, said that the Panoli plant is fully operational and the company hopes that the board and government will take positive action in the coming week, giving a green signal to the plant operations.
-
The government has allowed foreign direct investment in the development and production of seeds. In an interview with CNBC-TV18, Ashish Soparkar, MD, Meghmani Organics says, this is a good news for the company.
-
In an interview with CNBC-TV18, Natu Patel, MD, Meghmani Organics, spoke about the results and his outlook for the company.
